Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1.

[1]  A. Mobasheri,et al.  Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays. , 2010, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[2]  A. Carvalho,et al.  Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma , 2010, Molecules.

[3]  Z. Werb,et al.  Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. , 2010, Cancer research.

[4]  H. Gaisano,et al.  Hypoxia-reoxygenation increase invasiveness of PANC-1 cells through Rac1/MMP-2. , 2010, Biochemical and biophysical research communications.

[5]  C. Furuse,et al.  Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy , 2010, International journal of experimental pathology.

[6]  Shuihong Zhou,et al.  Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter‐1 , 2009, Head & neck.

[7]  T. Motyl,et al.  Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[8]  B. Luzar,et al.  Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis , 2009, Scandinavian journal of gastroenterology.

[9]  Jun Fan,et al.  Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism. , 2008, Cancer biotherapy & radiopharmaceuticals.

[10]  Qiulian Wu,et al.  Expression of Glucose Transporter-1 and -3 in the Head and Neck Carcinoma – The Correlation of the Expression with the Biological Behaviors , 2008, ORL.

[11]  G. Fleuren,et al.  EMMPRIN‐induced MMP‐2 activation cascade in human cervical squamous cell carcinoma , 2006, International journal of cancer.

[12]  R. Glazer,et al.  3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases , 2006, BMC Cancer.

[13]  L. Xi,et al.  Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK 4 and inactivation of MMP-2 , 2007, BMC Cancer.

[14]  Yuan Li,et al.  Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer. , 2004, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[15]  S. Ashley,et al.  Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity. , 2004, Surgery.

[16]  K. Ishikawa,et al.  Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. , 2004, Experimental cell research.

[17]  S. Ito,et al.  Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers. , 2002, Journal of the National Cancer Institute.

[18]  S. Tajima,et al.  Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant fibrous histiocytoma. , 2002, Journal of dermatological science.

[19]  Yuko Kobayashi,et al.  Claudin Promotes Activation of Pro-matrix Metalloproteinase-2 Mediated by Membrane-type Matrix Metalloproteinases* , 2001, The Journal of Biological Chemistry.

[20]  P. Wang,et al.  Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma. , 1999, Pathology oncology research : POR.